<?xml version="1.0" encoding="UTF-8"?>
<p id="p0150">Other medical manifestations of the COVID-19 infection include a vasculitis with risk of progressing to gangrene [
 <xref rid="bb0220" ref-type="bibr">[44]</xref>, 
 <xref rid="bb0225" ref-type="bibr">[45]</xref>, 
 <xref rid="bb0230" ref-type="bibr">[46]</xref>]. Some patients have evidence of spleen destruction and diffuse atrophy of lymph nodes, and their associated regional chains [
 <xref rid="bb0225" ref-type="bibr">45</xref>]. Others can harbor evidence of anti-phospholipid, anti-cardiolipin, and anti-Î²
 <sub>2</sub>-glycoprotein antibodies, each of which might signify the presence of a corresponding syndrome, with ramifications that only serve to intensify the demands upon patient management, and those responsible to deliver it [
 <xref rid="bb0235" ref-type="bibr">47</xref>].
</p>
